Question of the Day – Wednesday January 17, 2018
Question- It is unclear if PPIs are adequately efficacious for the treatment of gastro-esophageal reflux in infants and neonates and PPI treatment in this age group should be reserved for cases with serious and proven pathology. What are the adverse effects of PPIs that have been noted in this age group?
Question of the Day – Tuesday January 16, 2018
Question- What is the current prevalence rate for latex allergy?
Question of the Day – Monday January 15, 2018
Question- Is there an association between recent spermicide use and the development of acute pyelonephritis in healthy women?
Question of the Day – Friday January 12, 2018
Question: Does the maternal prenatal use of fluconazole increase the risk of congenital malformations in offspring?
Question of the Day – Thursday January 11, 2018
Question: What are the known risks of the occupational inhalation of dusts composed of nano- and micro-sized particles of tungsten carbide cobalt in metal manufacturing facilities and mining and drilling industries?
Question of the Day – Wednesday January 10, 2018
Question: Who does the American public blame as primarily responsible for the opioid abuse epidemic?
Question of the Day – Tuesday January 9, 2018
Question: Which epidemiological pre-cursors are required for the development of clinical favism?
Question of the Day – Monday January 8, 2018
Question: Which chemical has been proposed as a urinary biological marker of worker exposure to the chemical acrylamide?
Question of the Day – Friday January 5, 2018
Question: 4-Aminopyridine (4-AP) has been used in the treatment of a variety of diseases characterized by poor neuronal transmission including multiple sclerosis, spinal cord injury, botulism, Lambert-Eaton syndrome, and myasthenia gravis. What is the mechanism of action of 4-AP?
Question of the Day – Thursday January 4, 2018
Question: With regard to respirators used in the occupational setting, what is the so-called Assigned Protection Factor (APF)?
